The HBRC is associated with the Department of Medical Biophysics and Nuclear Medicine and benefits from its active support. The HBRC serves as a biomedical research center unique to the Middle East and Middle and Eastern Europe in that it combines several basic research programs with clinical applications of the most advanced medical imaging equipment. It is composed of four main units:

1.         The MRI/MRS laboratory of the HBRC, equipped with a Bruker 4.7T BioSpin system. It comprises the state-of-the-art software (latest version), several RF coils and means for animal physiological monitoring. In addition, the laboratory operates a small animal preparation room, including a small operation facility and several DELL data-stations computers for image analysis.

2.      A Positron Emission Tomography (PET)-Cyclotron unit, allowing functional imaging of the human body under physiological and pathological conditions. PET imaging is one of the most advanced technology in medical imaging. It makes use of short-lived radio-isotopes of natural chemicals of the body (produced by an onsite cyclotron) which permit to detect subtle changes in the chemistry of various organs (such as the brain during mental activities, the heart during stress and drug-induced stimulation, cancers at different stages in any part of the body) without any injury to the patient.

This is the only PET-Cyclotron unit that exists in Israel. It is run by the Medical Biophysics and Nuclear Medicine Department at Hadassah Hospital and provides specific radio-isotopes to other centers in the country.

3.      A unit of Image Computer Processing, Computer Modeling and Artificial Intelligence.

4.      A basic clinical and research laboratory with emphasis on cell biophysics and in-vivo proteomics, Immunology, and techniques for Immunotherapy. The infrastructure includes a stage P3-lab, equipped and expert in working with pathogenic microorganisms, eg. HIV. Its major research is centered on Diabetes and Multiple sclerosis as autoimmune diseases, as well as research in AIDS, developing the concept of T cell vaccination into clinical trials. This research is carried out in collaboration with Prof. I. Cohen and Prof. A. Ben Nun of the Weizmann Institute.